Literature DB >> 27080394

Transgenic overexpression of adenine nucleotide translocase 1 protects ischemic hearts against oxidative stress.

Inga Klumpe1,2, Konstantinos Savvatis3,4, Dirk Westermann5, Carsten Tschöpe3,6, Ursula Rauch1, Ulf Landmesser1, Heinz-Peter Schultheiss1, Andrea Dörner7,8.   

Abstract

UNLABELLED: Ischemia impairs the adenine nucleotide translocase (ANT), which transports ADP and ATP across the inner mitochondrial membrane. We investigated whether ANT1 overexpression has protective effects on ischemic hearts. Myocardial infarction was induced in wild-type (WT) and heart-specific ANT1-transgenic (ANT1-TG) rats, and hypoxia was set in isolated cardiomyocytes. ANT1 overexpression reduced the myocardial infarct area and increased the survival rate of infarcted rats. Reduced ANT1 expression and increased 4-hydroxynonenal modification of ANT paralleled to impaired ANT function in infarcted WT hearts. ANT1 overexpression improved ANT expression and function. This was accompanied by reduced mitochondrial cytochrome C release and caspase-3 activation. ANT1-TG hearts suffered less from oxidative stress, as shown by lower protein carbonylation and 4-hydroxynonenal modification of ANT. ANT1 overexpression also increased cell survival of hypoxic cardiomyocytes and attenuated reactive oxygen species (ROS) production. This was linked to higher stability of mitochondrial membrane potential and lower activity of ROS detoxifying catalase. ANT1-TG cardiomyocytes also showed higher resistance against H2O2 treatment, which was independent of catalase activity. In conclusion, ANT1 overexpression compensates impaired ANT activity under oxygen-restricted conditions. It reduces ROS production and oxidative stress, stabilizes mitochondrial integrity, and increases survival, making ANT1 a component in ROS management and heart protection during ischemia. KEY MESSAGES: ANT1 overexpression reduces infarct size and increases survival after infarction. ANT1 overexpression compensates restricted ANT expression and function in infarcted hearts. Increased ANT1 expression enhances mitochondrial integrity. ANT1-overexpressing hearts reduce oxidative stress by decreasing ROS generation. ANT1 is a component in ROS management and heart protection.

Entities:  

Keywords:  Adenine nucleotide translocase; Cardioprotection; Hypoxia; Ischemia; Mitochondria; Reactive oxygen species

Mesh:

Substances:

Year:  2016        PMID: 27080394     DOI: 10.1007/s00109-016-1413-4

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  32 in total

1.  Transcription of the adenine nucleotide translocase isoforms in various types of tissues in the rat.

Authors:  A Dörner; M Olesch; S Giessen; M Pauschinger; H P Schultheiss
Journal:  Biochim Biophys Acta       Date:  1999-02-04

2.  Ischemic-like change produced in canine heart by atractyloside: a chemical model.

Authors:  N Bittar; A L Shug; J D Folts; J R Koke
Journal:  Recent Adv Stud Cardiac Struct Metab       Date:  1976 May 26-29

3.  A mouse model for mitochondrial myopathy and cardiomyopathy resulting from a deficiency in the heart/muscle isoform of the adenine nucleotide translocator.

Authors:  B H Graham; K G Waymire; B Cottrell; I A Trounce; G R MacGregor; D C Wallace
Journal:  Nat Genet       Date:  1997-07       Impact factor: 38.330

4.  The adenine nucleotide translocator: a target of nitric oxide, peroxynitrite, and 4-hydroxynonenal.

Authors:  H L Vieira; A S Belzacq; D Haouzi; F Bernassola; I Cohen; E Jacotot; K F Ferri; C El Hamel; L M Bartle; G Melino; C Brenner; V Goldmacher; G Kroemer
Journal:  Oncogene       Date:  2001-07-19       Impact factor: 9.867

5.  Cardiac function and remodeling is attenuated in transgenic rats expressing the human kallikrein-1 gene after myocardial infarction.

Authors:  Matthias Koch; Frank Spillmann; Andreas Dendorfer; Dirk Westermann; Christine Altmann; Merdad Sahabi; Sophie Van Linthout; Michael Bader; Thomas Walther; Heinz-Peter Schultheiss; Carsten Tschöpe
Journal:  Eur J Pharmacol       Date:  2006-09-07       Impact factor: 4.432

6.  Formation of 4-hydroxy-2-nonenal-modified proteins in ischemic rat heart.

Authors:  P Eaton; J M Li; D J Hearse; M J Shattock
Journal:  Am J Physiol       Date:  1999-03

7.  Inhibition of adenine nucleotide translocator by lipid peroxidation products.

Authors:  J J Chen; H Bertrand; B P Yu
Journal:  Free Radic Biol Med       Date:  1995-11       Impact factor: 7.376

8.  Adenine nucleotide translocase 1 overexpression protects cardiomyocytes against hypoxia via increased ERK1/2 and AKT activation.

Authors:  Julia Winter; Inga Klumpe; Jacqueline Heger; Ursula Rauch; Heinz-Peter Schultheiss; Ulf Landmesser; Andrea Dörner
Journal:  Cell Signal       Date:  2015-11-05       Impact factor: 4.315

Review 9.  Pathophysiology of neutrophil-mediated extracellular redox reactions.

Authors:  Morana Jaganjac; Ana Cipak; Rudolf Joerg Schaur; Neven Zarkovic
Journal:  Front Biosci (Landmark Ed)       Date:  2016-01-01

Review 10.  The mitochondrial permeability transition: a current perspective on its identity and role in ischaemia/reperfusion injury.

Authors:  Andrew P Halestrap; Andrew P Richardson
Journal:  J Mol Cell Cardiol       Date:  2014-08-30       Impact factor: 5.000

View more
  12 in total

1.  ATP-ADP translocase and effects on ischemic heart.

Authors:  Friedrich C Luft
Journal:  J Mol Med (Berl)       Date:  2016-06       Impact factor: 4.599

2.  Cytoplasmic upregulation of Cyto c and AIF serve as biomarkers of mechanical asphyxia death.

Authors:  Heng Zhang; Yikai Hu; Hui Wang; Lu Tian; Wencan Li; Liujun Han; Hongmei Xu; Jianlong Ma; Kaijun Ma; Bi Xiao; Long Chen
Journal:  Am J Transl Res       Date:  2019-07-15       Impact factor: 4.060

Review 3.  Role of the immune system in cardiac tissue damage and repair following myocardial infarction.

Authors:  Arman Saparov; Vyacheslav Ogay; Talgat Nurgozhin; William C W Chen; Nurlan Mansurov; Assel Issabekova; Jamilya Zhakupova
Journal:  Inflamm Res       Date:  2017-06-09       Impact factor: 4.575

4.  Adenine nucleotide translocase regulates airway epithelial metabolism, surface hydration and ciliary function.

Authors:  Corrine R Kliment; Jennifer M K Nguyen; Mary Jane Kaltreider; YaWen Lu; Steven M Claypool; Josiah E Radder; Frank C Sciurba; Yingze Zhang; Alyssa D Gregory; Pablo A Iglesias; Venkataramana K Sidhaye; Douglas N Robinson
Journal:  J Cell Sci       Date:  2021-02-25       Impact factor: 5.285

Review 5.  The path from mitochondrial ROS to aging runs through the mitochondrial permeability transition pore.

Authors:  Hagai Rottenberg; Jan B Hoek
Journal:  Aging Cell       Date:  2017-07-31       Impact factor: 9.304

6.  Human adenine nucleotide translocases physically and functionally interact with respirasomes.

Authors:  Ya-Wen Lu; Michelle Grace Acoba; Kandasamy Selvaraju; Tai-Chung Huang; Raja S Nirujogi; Gajanan Sathe; Akhilesh Pandey; Steven M Claypool
Journal:  Mol Biol Cell       Date:  2017-04-12       Impact factor: 4.138

7.  Over-expression of mitochondrial creatine kinase in the murine heart improves functional recovery and protects against injury following ischaemia-reperfusion.

Authors:  Hannah J Whittington; Philip J Ostrowski; Debra J McAndrew; Fang Cao; Andrew Shaw; Thomas R Eykyn; Hannah A Lake; Jack Tyler; Jurgen E Schneider; Stefan Neubauer; Sevasti Zervou; Craig A Lygate
Journal:  Cardiovasc Res       Date:  2018-05-01       Impact factor: 10.787

8.  Proinflammatory NFkB signalling promotes mitochondrial dysfunction in skeletal muscle in response to cellular fuel overloading.

Authors:  Raid B Nisr; Dinesh S Shah; Ian G Ganley; Harinder S Hundal
Journal:  Cell Mol Life Sci       Date:  2019-05-17       Impact factor: 9.261

9.  The Role of Adenine Nucleotide Translocase in the Assembly of Respiratory Supercomplexes in Cardiac Cells.

Authors:  Rebecca M Parodi-Rullán; Xavier Chapa-Dubocq; Roberto Guzmán-Hernández; Sehwan Jang; Carlos A Torres-Ramos; Sylvette Ayala-Peña; Sabzali Javadov
Journal:  Cells       Date:  2019-10-13       Impact factor: 6.600

10.  ADP/ATP translocase 1 protects against an α-synuclein-associated neuronal cell damage in Parkinson's disease model.

Authors:  Wenyong Ding; Minghua Qi; Li Ma; Xuefei Xu; Yingfei Chen; Wenli Zhang
Journal:  Cell Biosci       Date:  2021-07-10       Impact factor: 7.133

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.